Jump to Navigation

Facebook Connect

User login

Should We Continue to AIM-HIGH or Set Our Sights Low?

Should We Continue to AIM-HIGH or Set Our Sights Low?


Schedule: On Demand (The original live program aired on December 15, 2011 at 7:00pm EST)

Program Overview:
The preliminary release of data from the AIM-HIGH trial left clinicians asking questions about the role of niacin therapy and raising HDL-C in patients at LDL goal. The final results from this trial were presented at the American Heart Association meeting on November 15, 2011. Join Drs. William Boden and James Falko as they discuss the implications of the study and the potential impact on your clinical practice in a live CME-CE webcast. Ask your questions of the expert faculty during the Q&A session at the conclusion of the activity.

Faculty
William E. Boden, MD, FACC
James M. Falko, MD, FACE, FACC, FNLA

Technical Support

This program requires a current version of ONE of the following web browsers, with JavaScript enabled:

  • Google Chrome
  • Firefox 5.0 or greater
  • Safari
  • Internet Explorer 8.0 or greater

This NLA Lipid Insights Archive Program is Mobile Device friendly. If you experience difficulty viewing the video portion of this program, please contact us.

The handouts portion of this program requires the Adobe Acrobat Reader or a similar PDF program. You probably already have it; but if you cannot view the handouts, you can obtain the Adobe Acrobat Reader here.

If you require assistance to view/hear this program, please contact us.

3
Average: 3 (1 vote)

Education Information

This program, though not accredited in its archived form, is targeted towards specific content areas and learning objectives.



Content Domain
This activity falls under the following content domain(s):

  • 1.2.4 HDL Metabolism

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Compare the relative effectiveness of existing treatments and emergent approaches to raise HDL and reduce CVD risk.
  2. Critically appraise recent clinical trials and apply important research to daily clinical practice.



by Dr. Radut.